Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

495 trials

NCT07226232
Recruiting
Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
Phase 3 · United States · 5 sites
Registry update: 23 Oct 2026
NCT07757997
Recruiting
Health and Work Ability Following Inpatient Treatment for Stress-related Disorders - Follow-up Study of the HARMODI Cohort
Not applicable · Switzerland · 1 site
Registry update: 11 Aug 2026
NCT07562191
Recruiting
Inhaled DMT for Major Depressive Disorder
Phase 2 · Brazil · 5 sites
Registry update: 13 Jul 2026
NCT07749521
Recruiting
Optimizing Treatment for Depressed Parents of Children With Emotional and Behavioural Problems
Not applicable · Canada · 1 site
Registry update: 6 Aug 2026
NCT07716098
Recruiting
A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression
Phase 3 · China, Japan, Taiwan, United States · 39 sites
Registry update: 3 Nov 2026
NCT07105397
Recruiting
Evaluating Conversational Artificial Intelligence for Depression Management
Not applicable · United States · 1 site
Registry update: 9 Sept 2026
NCT07263022
Recruiting
Cognitive Strategies in Early Psychosis 2
Phase 3 · United States · 1 site
Registry update: 23 Jul 2026
NCT07569198
Recruiting
Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT)
Phase 2 · Canada · 1 site
Registry update: 29 Jul 2026
NCT07834684
Recruiting
Singula Phase 0.1 Primary Care Pilot
Not applicable · United States · 2 sites
Registry update: 22 Sept 2026
NCT07211438
Recruiting
Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression
Phase 2 · Canada · 2 sites
Registry update: 21 Aug 2026
2024-512911-34-00
Recruiting
Efficacy of psilocybin and trazodone combination in treatment-resistant depression: a randomized controlled proof-of-concept study (PSILOTRAZ)
Phase 2 · France · 1 site
Registry update: 18 May 2026
NCT07210112
Recruiting
Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)
Phase 2 · France · 1 site
Registry update: 21 Sept 2026
NCT07621237
Recruiting
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
Phase 2 · United States · 27 sites
Registry update: 30 Oct 2026
NCT07843927
Recruiting
Dehydroepiandrosterone (DHEA) as Augmentation of Standard Antidepressants in Treatment-resistant Depression.
Phase 3 · Germany · 8 sites
Registry update: 28 Sept 2026
NCT06943573
Recruiting
Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder
Phase 2 · Canada · 3 sites
Registry update: 15 Sept 2026
NCT07611773
Recruiting
EEG Prediction and Clinical Efficacy of tDCS in Major Depression
Not applicable · Spain · 1 site
Registry update: 7 Jul 2026
NCT07633080
Recruiting
Magnesium Bisglycinate in Major Depressive Disorder
Not applicable · India · 1 site
Registry update: 15 Jun 2026
NCT07881016
Recruiting
French Minds Cohort: a French Longitudinal and Multimodal Cohort of Patients With Major Mood Disorders, Psychotic Disorders, Autism Spectrum Disorders, and Healthy Controls
Not applicable · France · 16 sites
Registry update: 19 Oct 2026
NCT07539805
Recruiting
Efficacy and Safety of Sertraline Combined With Lactobacillus Crispatus in Adolescents With Depression
Phase 2 · China · 2 sites
Registry update: 15 Jun 2026
NCT06832605
Recruiting
Mindfulness-Based Cognitive Therapy (MBCT) for the Prevention of Depression Relapse or Recurrence Using Videoconference
Not applicable · Spain · 5 sites
Registry update: 3 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.